Anti-CD55 [BU14]
Invented at University Of Birmingham
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 152149 |
| Applications | FACS IP |
| Antigen/Gene or Protein Targets | CD55 (CD97 ligand) |
| Synonyms | CD55 Molecule (Cromer Blood Group); CD55 Molecule; Decay Accelerating Factor For Complement (Cromer Blood Group); CD55 Antigen; DAF; CR; Decay Accelerating Factor For Complement; CROM; TC |
| Reactivity | Human |
| Relevance | CD97 is a member of the epidermal growth factor-seven transmembrane family. It affects tumour aggressiveness by binding its cellular ligand CD55 and exhibits adhesive properties. Previous studies have shown that CD97 and CD55 are involved in the dedifferentiation, migration, invasiveness and metastasis of tumours. |
| Host | Mouse |
| Subclass | IgG1 |
| Strain | Balb/c |
| Research Area | Adhesion, Cancer, Cell Type or Organelle Marker, Immunology |
References: 2 entries
Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.
IP
Origin and properties of soluble CD21 (CR2) in human blood.
Europe PMC ID: 9737663
Add a reference
References: 2 entries
Ling et al. 1998. Clin Exp Immunol. 113(3):360-6. PMID: 9737663.
IP
Origin and properties of soluble CD21 (CR2) in human blood.
Add a reference
